HLN is currently developing the following drugs: Stannous Fluoride Dentifrice, Stannous Fluoride And Potassium Nitrate Dentifrice, Potassium Nitrate Dentifrice, Vehicle Dentifrice, Paracetamol Odt, Alvedon Film-Coated Tablet, Panadol Film-Coated Tablet, Active Effervescent Powder, Nutrition Training And Healthy Lifestyle Coaching. These drug candidates are in various stages of clinical development as the company works toward FDA approval.